Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Point32Health | Vesicular Monoamine Transporter 2 (VMAT2) Inhibitors | New policy |
| Aug 2, 2026 | Point32Health | Veozah and Lynkuet | New policy |
| Aug 2, 2026 | Point32Health | Vemlidy (tenofovir alafenamide) | New policy |
| Aug 2, 2026 | Point32Health | Velsipity (etrasimod) | New policy |
| Aug 2, 2026 | Point32Health | Velphoro (sucroferric oxyhydroxide) | New policy |
| Aug 2, 2026 | Point32Health | Vascepa (icosapent ethyl) | New policy |
| Aug 2, 2026 | Point32Health | Vanrafia (atrasentan) | New policy |
| Aug 2, 2026 | Point32Health | Ustekinumab Subcutaneous Products | New policy |
| Aug 2, 2026 | Point32Health | Upneeq (oxmetazoline) | New policy |
| Aug 2, 2026 | Point32Health | Uceris (budesonide) | New policy |
| Aug 2, 2026 | Point32Health | Tremfya (guselkumab) Subcutaneous | New policy |
| Aug 2, 2026 | Point32Health | Topical Retinoids | New policy |
| Aug 2, 2026 | Point32Health | Topical Antifungal Agents | New policy |
| Aug 2, 2026 | Point32Health | Topical Acne Medications | New policy |
| Aug 2, 2026 | Point32Health | Tocilizumab Subcutaneous Products | New policy |
| Aug 2, 2026 | Point32Health | Tobi Podhaler (tobramycin) | New policy |
| Aug 2, 2026 | Point32Health | Thrombopoietin Receptor Agonists | New policy |
| Aug 2, 2026 | Point32Health | Thrombocytopenia Agents | New policy |
| Aug 2, 2026 | Point32Health | Tezspire (tezepelumab-ekko) pre-filled pen | New policy |
| Aug 2, 2026 | Point32Health | Tezspire (tezepelumab-ekko) Pre-filled Pen | New policy |
| Aug 2, 2026 | Point32Health | Tezspire (tezepelumab-ekko) Pre-filled Pen | New policy |
| Aug 2, 2026 | Point32Health | Testosterone Replacement Therapies | New policy |
| Aug 2, 2026 | Point32Health | Testosterone Products | New policy |
| Aug 2, 2026 | Point32Health | Tesamorelin Injection (Egrifta SV, Egrifta WR) | New policy |
| Aug 2, 2026 | Point32Health | Tegsedi (inotersen) | New policy |
| Aug 2, 2026 | Point32Health | Tarpeyo (budesonide) | New policy |
| Aug 2, 2026 | Point32Health | Tarpeyo (budesonide) | New policy |
| Aug 2, 2026 | Point32Health | Targeted Immunomodulators Self-administration | New policy |
| Aug 2, 2026 | Point32Health | Targeted Immunomodulators Self-administration | New policy |
| Aug 2, 2026 | Point32Health | Taltz (ixekizumab) | New policy |
| Aug 2, 2026 | Point32Health | Tafamidis Products | New policy |
| Aug 2, 2026 | Point32Health | Tafamidis Products | New policy |
| Aug 2, 2026 | Point32Health | Symlin (pramlintide) | New policy |
| Aug 2, 2026 | Point32Health | Sunosi (solriamfetol) and Wakix (pitolisant) | New policy |
| Aug 2, 2026 | Point32Health | Sucralfate oral suspension | New policy |
| Aug 2, 2026 | Point32Health | Strensiq (asfotase alfa) | New policy |
| Aug 2, 2026 | Point32Health | Spevigo (spesolimab-sbzo) | New policy |
| Aug 2, 2026 | Point32Health | Sovaldi (sofosbuvir) | New policy |
| Aug 2, 2026 | Point32Health | Sotyktu (deucravacitinib) | New policy |
| Aug 2, 2026 | Point32Health | Somatostatin Analogs | New policy |
| Aug 2, 2026 | Point32Health | Solosec (secnidazole) | New policy |
| Aug 2, 2026 | Point32Health | Sohonos (palovarotene) | New policy |
| Aug 2, 2026 | Point32Health | Sohonos (palovarotene) | New policy |
| Aug 2, 2026 | Point32Health | Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors | New policy |
| Aug 2, 2026 | Point32Health | Sodium Oxybate Products | New policy |
| Aug 2, 2026 | Point32Health | Smoking Cessation Products | New policy |
| Aug 2, 2026 | Point32Health | Skyrizi (risankizumab-rzaa) Subcutaneous | New policy |
| Aug 2, 2026 | Point32Health | Sivextro (tedizolid) | New policy |
| Aug 2, 2026 | Point32Health | Sirturo (bedaquiline) | New policy |
| Aug 2, 2026 | Point32Health | Sirturo (bedaquiline) | New policy |